Update on PCYC-1115-CA Randomised, Phase 3 study of Ibrutinib/Imbruvica versus Chlorambucil in Patients 65 yrs and untreated with CLL/SLL.
This is the first significant change to report, other than the reduction of lymph nodes after the first few weeks on the study which I began in September. (My neck, axillae and groin all clear now).
On Tuesday I had a CT scan at Bournemouth and on Thursday, the first 'study day' of my 5th cycle, I
This is the first significant change to report, other than the reduction of lymph nodes after the first few weeks on the study which I began in September. (My neck, axillae and groin all clear now).
On Tuesday I had a CT scan at Bournemouth and on Thursday, the first 'study day' of my 5th cycle, I